Building a Culture of Innovation


New ideas are fundamental if companies are to retain a competitive edge.

Criticaleye speaks to Anand Gupta, Martin Grieve, Jane Griffiths, Martin Hess, Costas Markides and Mark Wood to find out how an environment can be created where people aren't afraid to think differently. 

Share this with your Community


Contributors
Anand Gupta
Growth Partner
Tata Consultancy Services
Costas Markides
Professor of Strategy and Entrepreneurship
London Business School
Jane Griffiths
Board Mentor
Criticaleye
Mark Wood
Former SVP & Managing Director Europe, Middle East and Africa
Revlon International
Martin Grieve
Advisory Board Member
Model Britain
Martin Hess
Chair
Telefonica Tech UK&I


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

BLOG | What Sets World-Class CEOs Apart in Uncertain Times?

If you're a CEO today, you’re likely feeling the pressure to be a technologist, a geopolitical expert and a visionary all at once. Markets are shifting rapidly, the operating...


Click here to download this insight

Health and Wellbeing at Work

The CIPD’s 2025 Health and Wellbeing at Work report, supported by Criticaleye CPO Retreat 2026 Partner Simplyhealth, examines health, wellbeing and attendance trends and challenges. Now in its 24th edition, t...


Inspiring Leaders Podcast: Sally Bridgeland, Chair, Development Bank of Wales and Keith Cochrane, Chair, Schenck Process Group, on Risk in the Boardroom

In this episode, Sally Bridgeland, Chair, Development Bank of Wales, Nest Invest and BelleVie Care and Keith Cochrane, Chair, Schenck Process Group talk about what risks will be on the Board agenda this yea...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 201




Mayborn Group London Stock Exchange Group NATS E.ON UK Lightsource bp LACE Partners Drax Group plc Canaccord Genuity Group Inc Rolls-Royce Legal & General Hitachi Solutions Worldpay NatWest Group British Land Aldermore Group AlixPartners GlaxoSmithKline plc